Cara Therapeutics (NQ: CARA )

10.99 USD -0.40 (-3.51%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2022 Add to My Watchlist

Price and Volume

Volume	314,963
Open	11.46
Bid (Size)	10.92 (5)
Ask (Size)	11.49 (2)
Prev. Close	11.39
Today's Range	10.93 - 11.66
52wk Range	10.83 - 29.65
Shares Outstanding	53,458,679
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cara Therapeutics Announces Late-Breaking Presentation at 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress

September 29, 2021

Results from KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus to be presented

Cara Therapeutics to Present at the the 2021 Cantor Virtual Global Healthcare Conference

September 24, 2021

Performance

YTD	-13.12%	-13.12%
1 Month	-10.29%	-10.29%
3 Month	-35.16%	-35.16%
6 Month	-9.92%	-9.92%
1 Year	-40.75%	-40.75%

More News

Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack

December 14, 2021

XPO Logistics (Formerly Segmentz) Founder and Grove Inc (GRVI) CEO Brings Deep Experience in Growing Companies

November 10, 2021

How The Parts Add Up: IJS Targets $118

October 29, 2021

Notable Tuesday Option Activity: SMG, CARA, ABR

October 26, 2021

Cara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcript

November 08, 2021

IHE's Underlying Holdings Could Mean 23% Gain Potential

September 27, 2021

3 Explosive Biotech Stocks -- Could They Shoot Even Higher?

November 03, 2021

Analysts Anticipate SLYG Will Reach $102

August 26, 2021

Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval

September 04, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.